Clostridium Difficile Infection clinical trials

Explore recruiting clostridium difficile infection clinical trials.

Recruiting clostridium difficile infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Clostridium Difficile Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

VANCALLO - Prevention of C. difficile infections by oral vancomycin in patients treated for allogeneic hematopoietic stem cell transplantation, a randomized double-blind placebo-controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, non-inferiority interventional study

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Trial to evaluate the administration of IDOR-1134-2831 vaccine in healthy participants

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

(SPARROW) Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple’s procedure (SPARROW): a multicenter, randomized controlled trial

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

PROPHYLOXITIN-Intermittent cefoxitin administration versus loading bolus followed by continuous infusion for the prevention of surgical site infection in colorectal surgery: a multicentre, double-blind, randomized controlled clinical trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Fecal Microbiota Transplantation in the prevention of complications after allogeneic hematopoietic stem cell transplantation for hematologic malignancy

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Clostridium Difficile Infection trials by city

Clostridium Difficile Infection in Toronto Clostridium Difficile Infection in Vancouver Clostridium Difficile Infection in Montreal Clostridium Difficile Infection in Calgary Clostridium Difficile Infection in Edmonton Clostridium Difficile Infection in Ottawa Clostridium Difficile Infection in Winnipeg Clostridium Difficile Infection in Quebec City Clostridium Difficile Infection in Hamilton Clostridium Difficile Infection in Kitchener Clostridium Difficile Infection in London Clostridium Difficile Infection in Halifax Clostridium Difficile Infection in New York Clostridium Difficile Infection in Los Angeles Clostridium Difficile Infection in Chicago Clostridium Difficile Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease